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Background
Acromegaly is a rare endocrine disorder with excess
growth hormone (GH) production. This disorder has
important metabolic effects in insulin resistance and
lipolysis. The objective of this study was to explore tran-
scriptional changes induced by GH in adipose tissue.
Materials and methods
Patients with acromegaly (n=9) or non-functioning
pituitary adenoma (n=11) were prospectively observed
from March 2011 to June 2012. The patients underwent
clinical and metabolic profiling including assessment of
HOMA-IR. Explants of adipose tissue were assayed ex-
vivo for lipolysis and ceramide levels. Adipose tissue was
analyzed by RNA sequencing (RNAseq).
Results
There was evidence of reduced insulin sensitivity based
on the increase in fasting glucose, insulin and HOMA-IR
score. We observed several previously reported transcrip-
tional changes (IGF1, IGFBP3) as well as several novel
transcriptional changes, some of which may be important
for GH signal regulation (PTPN3 and PTPN4) and the
effect of GH on growth and proliferation. Several tran-
scripts could potentially be important in GH-induced
metabolic changes. Specifically, induction of LPL,
ABHD5, ACVR1C could contribute to enhanced lipolysis
and may explain the suggestive enhancement of adipose
tissue lipolysis in acromegaly patients as reflected by gly-
cerol release from the explants of the two groups of
patients (p=0.09). Higher expression of SCD and TCF7L2
could contribute to insulin resistance. Expression of
HSD11B1 was reduced and GR was increased, predicting
modified glucocorticoid activity in acromegaly.
Conclusions
We identified the acromegaly gene expression signature
in human adipose tissue. The significance of altered
expression of specific transcripts will enhance our
understanding of the metabolic and proliferative changes
associated with acromegaly.
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